These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30859684)

  • 41. Pachyonychia congenita in Japan: report of familial cases with a recurrent KRT16 mutation.
    Inaba Y; Kanazawa N; Furukawa F; Sakurane Y; Nakano H; Sawamura D; Yoneda K; Hamada T; Hashimoto T
    Eur J Dermatol; 2014; 24(1):122-3. PubMed ID: 24491404
    [No Abstract]   [Full Text] [Related]  

  • 42. Pachyonychia congenita: a case report.
    Kohli N
    Cutis; 2009 Nov; 84(5):269-71. PubMed ID: 20099620
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oxidative stress and dysfunctional NRF2 underlie pachyonychia congenita phenotypes.
    Kerns ML; Hakim JM; Lu RG; Guo Y; Berroth A; Kaspar RL; Coulombe PA
    J Clin Invest; 2016 Jun; 126(6):2356-66. PubMed ID: 27183391
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gene expression profiling in pachyonychia congenita skin.
    Cao YA; Hickerson RP; Seegmiller BL; Grapov D; Gross MM; Bessette MR; Phinney BS; Flores MA; Speaker TJ; Vermeulen A; Bravo AA; Bruckner AL; Milstone LM; Schwartz ME; Rice RH; Kaspar RL
    J Dermatol Sci; 2015 Mar; 77(3):156-65. PubMed ID: 25656049
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genotype‒Structurotype‒Phenotype Correlations in Patients with Pachyonychia Congenita.
    Wu TT; Eldirany SA; Bunick CG; Teng JMC
    J Invest Dermatol; 2021 Dec; 141(12):2876-2884.e4. PubMed ID: 34116063
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel and recurrent keratin 6A (KRT6A) mutations in Chinese patients with pachyonychia congenita type 1.
    Lv YM; Yang S; Zhang Z; Cui Y; Quan C; Zhou FS; Fang QY; Du WH; Zhang FR; Chang JM; Tao XP; Zhang AL; Kang RH; Du WD; Zhang XJ
    Br J Dermatol; 2009 Jun; 160(6):1327-9. PubMed ID: 19416275
    [No Abstract]   [Full Text] [Related]  

  • 47. Diffuse and focal palmoplantar keratoderma can be caused by a keratin 6c mutation.
    Akasaka E; Nakano H; Nakano A; Toyomaki Y; Takiyoshi N; Rokunohe D; Nishikawa Y; Korekawa A; Matsuzaki Y; Mitsuhashi Y; Sawamura D
    Br J Dermatol; 2011 Dec; 165(6):1290-2. PubMed ID: 21801157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pachyonychia congenita type 2, N92S mutation of keratin 17 gene: clinical features, mutation analysis and pathological view.
    Cogulu O; Onay H; Aykut A; Wilson NJ; Smith FJ; Dereli T; Ozkinay F
    Eur J Pediatr; 2009 Oct; 168(10):1269-72. PubMed ID: 19107515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Altered keratinocyte differentiation is an early driver of keratin mutation-based palmoplantar keratoderma.
    Zieman AG; Poll BG; Ma J; Coulombe PA
    Hum Mol Genet; 2019 Jul; 28(13):2255-2270. PubMed ID: 31220272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enamel Anomalies in a Pachyonychia Congenita Patient with a Mutation in KRT16.
    Duverger O; Cross MA; Smith FJD; Morasso MI
    J Invest Dermatol; 2019 Jan; 139(1):238-241. PubMed ID: 30009827
    [No Abstract]   [Full Text] [Related]  

  • 51. Genotype-phenotype correlations of neurovascular structures on the feet in patients with pachyonychia congenita: A cross-sectional study.
    Tan XL; Thomas BR; Steele L; Schwartz J; Hansen CD; O'Toole EA
    J Am Acad Dermatol; 2022 Nov; 87(5):1172-1174. PubMed ID: 35245567
    [No Abstract]   [Full Text] [Related]  

  • 52. Pachyonychia congenita associated with median rhomboid glossitis.
    Karen JK; Schaffer JV
    Dermatol Online J; 2007 Jan; 13(1):21. PubMed ID: 17511954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Paternal germ cell mosaicism in autosomal dominant pachyonychia congenita.
    Pho LN; Smith FJ; Konecki D; Bale S; McLean WH; Cohen B; Eliason MJ; Leachman SA
    Arch Dermatol; 2011 Sep; 147(9):1077-80. PubMed ID: 21576551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel proline substitution mutations in keratin 16 in two cases of pachyonychia congenita type 1.
    Smith FJ; Del Monaco M; Steijlen PM; Munro CS; Morvay M; Coleman CM; Rietveld FJ; Uitto J; McLean WH
    Br J Dermatol; 1999 Dec; 141(6):1010-6. PubMed ID: 10606845
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pachyonychia congenita in pediatric patients: natural history, features, and impact.
    Shah S; Boen M; Kenner-Bell B; Schwartz M; Rademaker A; Paller AS
    JAMA Dermatol; 2014 Feb; 150(2):146-53. PubMed ID: 24132595
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proteomic profiling of Pachyonychia congenita plantar callus.
    Rice RH; Durbin-Johnson BP; Salemi M; Schwartz ME; Rocke DM; Phinney BS
    J Proteomics; 2017 Aug; 165():132-137. PubMed ID: 28648685
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The 521 T--> C mutation in the keratin 6A gene in a pedigree with pachyonychia congenita type I].
    Yang L; Li M; Lai M; Ni J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):66-8. PubMed ID: 20140871
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An appraisal of oral retinoids in the treatment of pachyonychia congenita.
    Gruber R; Edlinger M; Kaspar RL; Hansen CD; Leachman S; Milstone LM; Smith FJ; Sidoroff A; Fritsch PO; Schmuth M
    J Am Acad Dermatol; 2012 Jun; 66(6):e193-9. PubMed ID: 21601946
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Scrutinising the role of simvastatin in a patient of Pachyonychia Congenita with KRT6A gene mutation.
    Sharma S; Dayal S; Aggarwal K; Gowda V M V; Kaur R
    Australas J Dermatol; 2022 May; 63(2):e145-e149. PubMed ID: 35429339
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.